Journal of clinical and translational hepatology

· 6 papers in corpus
2024
doi:10.14218/jcth.2023.00562 ·PMID:38974954

Background and aimsHepatic fibrosis (HF) is a critical step in the progression of hepatocellular carcinoma (HCC). Gene associated with retinoid-IFN-induced mortality 19 (GRIM19), an essential component of mitochondrial respiratory chain com…

2023
doi:10.14218/jcth.2022.00351 ·PMID:36969882

Gallbladder carcinoma (GBC) is a malignant tumor of the biliary system that is aggressive, difficult to detect early, and has a low surgical resection rate and poor prognosis. Appropriate in vitro growth models are expected to focus on the …

2018
doi:10.14218/jcth.2017.00070 ·PMID:30271734

Background and Aims: To evaluate the prevalence and significance of elevated cancer antigen-125 (CA-125) levels in patients with cirrhosis being treated in a tertiary care liver center and its correlation with objective markers of disease s…

2018
doi:10.14218/jcth.2017.00069 ·PMID:29951366

Hepatic cysts (HCs) are frequently discovered incidentally on abdominal imaging. The prevalence of HCs has been reported as high as 15-18% in the United States. Although most cysts are benign, some are malignant or premalignant. It is impor…

2015
doi:10.14218/jcth.2014.00039 ·PMID:26357631

The porphyrias comprise a set of diseases, each representing an individual defect in one of the eight enzymes mediating the pathway of heme synthesis. The diseases are genetically distinct but have in common the overproduction of heme precu…

2014
doi:10.14218/jcth.2014.00024 ·PMID:26357630

Primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) are two major types of chronic cholestatic liver disease. Each disorder has distinguishing features and variable progression, but both may ultimately result in cirrhos…